BioRestorative Therapies (BRTX) vs PMGC (ELAB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
BioRestorative Therapies is the larger company by market cap ($2.6 million vs $2.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRTX | ELAB |
|---|---|---|
| Share price | $1.86 | $3.07 |
| Market cap | $2.57M | $2.49M |
| 1-day change | -1.59% | -1.29% |
| EPS (TTM) | $-21.40 | $-1,748.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $34.40 | $2,671.20 |
| 52-week low | $1.75 | $2.59 |
| Distance from 52-week high | -94.59% | -99.89% |
| Analyst consensus | buy | — |
| Avg. price target upside | +16029.03% | — |
| Average volume | 26.05K | 127.38K |
| Shares outstanding | 1.38M | 809.58K |
| Employees | 13 | 32 |
| Sector | Health Care | Health Care |
| Industry | Managed Health Care | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About BioRestorative Therapies
BRTX stock →BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
Health Care · Managed Health Care · 13 employees
About PMGC
ELAB stock →PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
BRTX vs ELAB FAQ
Which is bigger, BioRestorative Therapies or PMGC?
BioRestorative Therapies (BRTX) is larger, with a market capitalization of $2.57M compared with $2.49M for PMGC (ELAB).
Are BioRestorative Therapies and PMGC in the same industry?
Both are in the Health Care sector, but in different industries: Managed Health Care for BioRestorative Therapies and Biotechnology: Pharmaceutical Preparations for PMGC.